{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:36:39Z","timestamp":1793892999009,"version":"4.8.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017160","name":"Beni Suef University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017160","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>In nosocomial settings, vancomycin-resistant <jats:italic>Enterococcus faecalis<\/jats:italic> is a major health threat leading to increased morbidities, mortalities, and treatment costs. Nowadays, several approaches are under investigation to enhance the activity of or replace the traditional antibiotics. Bacteriophage therapy was sought as a potential approach for combating <jats:italic>E. faecalis<\/jats:italic> infections. The present study focuses on isolating and characterizing bacteriophage against clinical multi-drug resistant (MDR) <jats:italic>E. faecalis<\/jats:italic> strain Lb-1492. The phage stability, lytic activity, host-range, latent period, burst size, the ability to detach the pre-formed biofilm and destroy entrapped cells were investigated. The phage genome was purified, sequenced, and subjected to bioinformatics analysis for identifying and characterizing its features, as well as, the suitability for clinical application. Finally, the ability of the phage to rescue mice from deadly, experimentally induced <jats:italic>E. faecalis<\/jats:italic> bacteremia was evaluated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A virulent phage was isolated from sewage water against a clinical MDR <jats:italic>E. faecalis<\/jats:italic> isolate. Morphological and genomic studies indicated that the phage belongs to the <jats:italic>Efquatrovirus<\/jats:italic> genus, with a long tail, icosahedral head and a linear double-stranded DNA genome of approximately 42.9 kbp. The phage was named <jats:italic>vB<\/jats:italic>_Efa_ZAT1 (shortly ZAT1). It demonstrated a shorter latent period and larger burst size than regular-tailed phages, and a characteristic stability over a wide range of pH and temperatures, with the optimum activity at pH 7.4 and 37\u00a0\u00b0C, respectively. Phage ZAT1 showed a narrow spectrum of activity and a characteristic biofilm disruption ability. The phage managed successfully to control <jats:italic>E. faecalis<\/jats:italic>-induced bacteremia in mice models, which was lethal within 48\u00a0h in the control group. An intraperitoneal injection of 3\u2009\u00d7\u200910<jats:sup>8<\/jats:sup> PFU of the phage solution given 1\u00a0h after the bacterial challenge was sufficient to save all the animals, completely reversing the trend of 100% mortality caused by this bacterium.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Phage therapy can be a promising alternative to traditional antibiotics in the post-antibiotic era with a significant antimicrobial and antibiofilm activities against MDR <jats:italic>E. faecalis<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12866-025-03785-z","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:00:02Z","timestamp":1740027602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Therapeutic potential of a newly isolated bacteriophage against multi-drug resistant Enterococcus faecalis infections: in vitro and in vivo characterization"],"prefix":"10.1186","volume":"25","author":[{"given":"Zienab","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Abdelkader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha M.","family":"Abdel-Fattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Farag","family":"Azmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed O.","family":"El-Gendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Dishisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"3785_CR1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.amjmed.2006.03.011","volume":"119","author":"FC Tenover","year":"2006","unstructured":"Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J Med. 2006;119:S3\u201310.","journal-title":"Am J Med"},{"key":"3785_CR2","doi-asserted-by":"crossref","unstructured":"Pereira LB, Zanetti MOB, Sponchiado LP, Rodrigues JPV, Campos MS, de Varallo A. FR, Antibiotic use in Brazilian hospitals in the 21st century: a systematic review. Rev Soc Bras Med Trop. 2021;54.","DOI":"10.1590\/0037-8682-0861-2020"},{"key":"3785_CR3","unstructured":"Polishchuck NM, Matylonok TY, Kyryk DL, Alimenko YL. Molecular aspects of bacterial resistance to antibiotics. Ann Mechnikov\u2019s Inst. 2021;2:6\u201311."},{"key":"3785_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJ Murray","year":"2022","unstructured":"Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629\u201355.","journal-title":"Lancet"},{"key":"3785_CR5","doi-asserted-by":"publisher","first-page":"3979482","DOI":"10.1155\/2020\/3979482","volume":"2020","author":"IF Jaja","year":"2020","unstructured":"Jaja IF, Jaja C-JI, Chigor NV, Anyanwu MU, Maduabuchi EK, Oguttu JW, et al. Antimicrobial resistance phenotype of Staphylococcus aureus and Escherichia coli isolates obtained from meat in the formal and informal sectors in South Africa. Biomed Res Int. 2020;2020:3979482.","journal-title":"Biomed Res Int"},{"key":"3785_CR6","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3390\/antibiotics9120873","volume":"9","author":"WC Chai","year":"2020","unstructured":"Chai WC, Whittall JJ, Song D, Polyak SW, Ogunniyi AD, Wang Y, et al. Antimicrobial action and reversal of resistance in MRSA by difluorobenzamide derivatives targeted at FtsZ. Antibiotics. 2020;9:873.","journal-title":"Antibiotics"},{"key":"3785_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41579-020-0386-z","volume":"18","author":"DN Wilson","year":"2020","unstructured":"Wilson DN, Hauryliuk V, Atkinson GC, O\u2019Neill AJ. Target protection as a key antibiotic resistance mechanism. Nat Rev Microbiol. 2020;18:637\u201348.","journal-title":"Nat Rev Microbiol"},{"key":"3785_CR8","doi-asserted-by":"crossref","unstructured":"Angst DC, Tepekule B, Sun L, Bogos B, Bonhoeffer S. Comparing treatment strategies to reduce antibiotic resistance in an in vitro epidemiological setting. Proc Natl Acad Sci. 2021;118:e2023467118.","DOI":"10.1073\/pnas.2023467118"},{"key":"3785_CR9","doi-asserted-by":"publisher","first-page":"9446","DOI":"10.3934\/math.2021549","volume":"6","author":"E Ibarg\u00fcen-Mondrag\u00f3n","year":"2021","unstructured":"Ibarg\u00fcen-Mondrag\u00f3n E, G\u00f3mez MC, Burbano-Rosero EM. Assessing the role of bacterial plasmid replication in a competition model of sensitive and resistant bacteria to antibiotics. AIMS Math. 2021;6:9446\u201367.","journal-title":"AIMS Math"},{"key":"3785_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14715\/cmb\/2018.64.13.1","volume":"64","author":"M Beomidehagh","year":"2018","unstructured":"Beomidehagh M, Rezaee MA, Ganbarov K, Jafari F, Hasani A, Alizadeh N, et al. Effect of acidic and alkali shocks on expression of efaA gene in Enterococcus faecalis, isolated from root canal infection. Cell Mol Biol. 2018;64:1\u20135.","journal-title":"Cell Mol Biol"},{"key":"3785_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/BF01963631","volume":"9","author":"C Chenoweth","year":"1990","unstructured":"Chenoweth C, Schaberg D. The epidemiology of enterococci. Eur J Clin Microbiol Infect Dis. 1990;9:80\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3785_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/ice.2019.296","volume":"41","author":"LM Weiner-Lastinger","year":"2020","unstructured":"Weiner-Lastinger LM, Abner S, Edwards JR, Kallen AJ, Karlsson M, Magill SS, et al. Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015\u20132017. Infect Control Hosp Epidemiol. 2020;41:1\u201318.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"3785_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.scitotenv.2017.07.121","volume":"609","author":"V Oravcova","year":"2017","unstructured":"Oravcova V, Mihalcin M, Zakova J, Pospisilova L, Masarikova M, Literak I. Vancomycin-resistant enterococci with vanA gene in treated municipal wastewater and their association with human hospital strains. Sci Total Environ. 2017;609:633\u201343.","journal-title":"Sci Total Environ"},{"key":"3785_CR14","doi-asserted-by":"crossref","unstructured":"Pandey RP, Mukherjee R, Chang C-M. Antimicrobial Resistance Surveillance System Mapping in Different Countries. Preprints; 2022 [cited 2022 Aug 7]; Available from: https:\/\/www.preprints.org\/manuscript\/202201.0234\/v1","DOI":"10.20944\/preprints202201.0234.v1"},{"key":"3785_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2180-8-43","volume":"8","author":"SE Dowd","year":"2008","unstructured":"Dowd SE, Sun Y, Secor PR, Rhoads DD, Wolcott BM, James GA, et al. Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol. 2008;8:43.","journal-title":"BMC Microbiol"},{"key":"3785_CR16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1128\/CMR.14.2.244-269.2001","volume":"14","author":"PG Bowler","year":"2001","unstructured":"Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev. 2001;14:244\u201369.","journal-title":"Clin Microbiol Rev"},{"key":"3785_CR17","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1093\/infdis\/jix541","volume":"216","author":"KKL Chong","year":"2017","unstructured":"Chong KKL, Tay WH, Janela B, Yong AMH, Liew TH, Madden L, et al. Enterococcus faecalis modulates immune activation and slows healing during wound infection. J Infect Dis. 2017;216:1644\u201354.","journal-title":"J Infect Dis"},{"key":"3785_CR18","unstructured":"WHO. Global guidelines for the prevention of surgical site infection. World Health Organization; 2016."},{"key":"3785_CR19","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.2217\/fmb.09.82","volume":"4","author":"RJ Willems","year":"2009","unstructured":"Willems RJ, van Schaik W. Transition of Enterococcus faecium from commensal organism to nosocomial pathogen. Future Microbiol. 2009;4:1125\u201335.","journal-title":"Future Microbiol"},{"key":"3785_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.tim.2017.01.004","volume":"25","author":"RM van Harten","year":"2017","unstructured":"van Harten RM, Willems RJL, Martin NI, Hendrickx APA. Multidrug-resistant enterococcal infections: new compounds, novel antimicrobial therapies? Trends Microbiol. 2017;25:467\u201379.","journal-title":"Trends Microbiol"},{"key":"3785_CR21","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s40121-020-00342-1","volume":"9","author":"W Yu","year":"2020","unstructured":"Yu W, Zhang J, Tong J, Zhang L, Zhan Y, Huang Y, et al. In vitro antimicrobial activity of fosfomVancomycinomycin and daptomycin alone, and in combination, against linezolid-resistant Enterococcus faecalis. Infect Dis Ther. 2020;9:927\u201334.","journal-title":"Infect Dis Ther"},{"key":"3785_CR22","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1128\/AAC.49.7.2954-2958.2005","volume":"49","author":"S Ono","year":"2005","unstructured":"Ono S, Muratani T, Matsumoto T. Mechanisms of resistance to imipenem and ampicillin in Enterococcus faecalis. Antimicrob Agents Chemother. 2005;49:2954\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"3785_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41522-017-0023-4","volume":"3","author":"JL Dale","year":"2017","unstructured":"Dale JL, Nilson JL, Barnes AMT, Dunny GM. Restructuring of Enterococcus faecalis biofilm architecture in response to antibiotic-induced stress. Npj Biofilms Microbiomes. 2017;3:15.","journal-title":"Npj Biofilms Microbiomes"},{"key":"3785_CR24","doi-asserted-by":"publisher","first-page":"26925","DOI":"10.1073\/pnas.1916037116","volume":"116","author":"A Khan","year":"2019","unstructured":"Khan A, Davlieva M, Panesso D, Rincon S, Miller WR, Diaz L, et al. Antimicrobial sensing coupled with cell membrane remodeling mediates antibiotic resistance and virulence in Enterococcus faecalis. Proc Natl Acad Sci. 2019;116:26925\u201332.","journal-title":"Proc Natl Acad Sci"},{"key":"3785_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4161\/viru.21282","volume":"3","author":"BL Hollenbeck","year":"2012","unstructured":"Hollenbeck BL, Rice LB. Intrinsic and acquired resistance mechanisms in Enterococcus. Virulence. 2012;3:421\u2013569.","journal-title":"Virulence"},{"key":"3785_CR26","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fmicb.2012.00238","volume":"3","author":"EC Keen","year":"2012","unstructured":"Keen EC. Phage therapy: concept to cure. Front Microbiol. 2012;3:238.","journal-title":"Front Microbiol"},{"key":"3785_CR27","doi-asserted-by":"publisher","first-page":"7031","DOI":"10.3390\/ijms22137031","volume":"22","author":"HYP Lam","year":"2021","unstructured":"Lam HYP, Lai M-J, Chen T-Y, Wu W-J, Peng S-Y, Chang K-C. Therapeutic effect of a newly isolated lytic bacteriophage against multi-drug-resistant Cutibacterium acnes infection in mice. Int J Mol Sci. 2021;22:7031.","journal-title":"Int J Mol Sci"},{"key":"3785_CR28","doi-asserted-by":"crossref","unstructured":"Malik S, Nehra K, Rana JS. Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli. Virus Res. 2021;198496.","DOI":"10.1016\/j.virusres.2021.198496"},{"key":"3785_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.copbio.2021.03.002","volume":"68","author":"JY Nale","year":"2021","unstructured":"Nale JY, Clokie MRJ. Preclinical data and safety assessment of phage therapy in humans. Curr Opin Biotechnol. 2021;68:310\u20137.","journal-title":"Curr Opin Biotechnol"},{"key":"3785_CR30","first-page":"389","volume":"10","author":"DS Dutta","year":"2021","unstructured":"Dutta DS, Sarkar DR, Bordoloi DKP, Deka DC, Sonowal DPJ. Bacteriophage therapy to combat antibiotic resistance: a brief review. Pharma Innov J. 2021;10:389\u201394.","journal-title":"Pharma Innov J"},{"key":"3785_CR31","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3390\/antibiotics10050556","volume":"10","author":"D Holger","year":"2021","unstructured":"Holger D, Kebriaei R, Morrisette T, Lev K, Alexander J, Rybak M. Clinical pharmacology of bacteriophage therapy: a focus on multidrug-resistant Pseudomonas aeruginosa infections. Antibiotics. 2021;10:556.","journal-title":"Antibiotics"},{"key":"3785_CR32","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/vde.12958","volume":"32","author":"RA Squires","year":"2021","unstructured":"Squires RA. Bacteriophage therapy for challenging bacterial infections: achievements, limitations and prospects for future clinical use by veterinary dermatologists. Vet Dermatol. 2021;32:587\u2013e158.","journal-title":"Vet Dermatol"},{"key":"3785_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4161\/bact.1.2.14590","volume":"1","author":"C Loc-Carrillo","year":"2011","unstructured":"Loc-Carrillo C, Abedon ST. Pros and cons of phage therapy. Bacteriophage. 2011;1:111\u20134.","journal-title":"Bacteriophage"},{"key":"3785_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.33073\/pjm-2014-019","volume":"63","author":"S Parasion","year":"2014","unstructured":"Parasion S, Kwiatek M, Gryko R, Mizak L, Malm A. Bacteriophages as an alternative strategy for fighting biofilm development. Pol J Microbiol. 2014;63:137\u201345.","journal-title":"Pol J Microbiol"},{"key":"3785_CR35","doi-asserted-by":"publisher","first-page":"698807","DOI":"10.3389\/fcimb.2021.698807","volume":"11","author":"M Song","year":"2021","unstructured":"Song M, Wu D, Hu Y, Luo H, Li G. Characterization of an Enterococcus faecalis bacteriophage vB_EfaM_LG1 and its synergistic Effect with Antibiotic. Front Cell Infect Microbiol. 2021;11:698807.","journal-title":"Front Cell Infect Microbiol"},{"key":"3785_CR36","doi-asserted-by":"crossref","unstructured":"Holger DJ, Lev KL, Kebriaei R, Morrisette T, Shah R, Alexander J, et al. Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testing. J Appl Microbiol. 2022;133:1636\u201349.","DOI":"10.1111\/jam.15647"},{"key":"3785_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/spectrum.00427-24","volume":"12","author":"AJ Kunz Coyne","year":"2024","unstructured":"Kunz Coyne AJ, Eshaya M, Bleick C, Vader S, Biswas B, Wilson M, et al. Exploring synergistic and antagonistic interactions in phage-antibiotic combinations against ESKAPE pathogens. Microbiol Spectr. 2024;12:10.","journal-title":"Microbiol Spectr"},{"key":"3785_CR38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/v11020096","volume":"11","author":"K Abdelkader","year":"2019","unstructured":"Abdelkader K, Gerstmans H, Saafan A, Dishisha T, Briers Y. The preclinical and clinical progress of bacteriophages and their lytic enzymes: the parts are easier than the whole. Viruses. 2019;11:96.","journal-title":"Viruses"},{"key":"3785_CR39","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","volume":"25","author":"KE Kortright","year":"2019","unstructured":"Kortright KE, Chan BK, Koff JL, Turner PE. Phage therapy: a renewed approach to combat antibiotic-resistant bacteria. Cell Host Microbe. 2019;25:219\u201332.","journal-title":"Cell Host Microbe"},{"key":"3785_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43088-023-00362-z","volume":"12","author":"Z Ali","year":"2023","unstructured":"Ali Z, Dishisha T, El-Gendy AO, Azmy AF. Isolation and phenotypic characterization of bacteriophage SA14 with lytic-and anti-biofilm activity against multidrug-resistant Enterococcus faecalis. Beni-Suef Univ J Basic Appl Sci. 2023;12:1\u201310.","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"key":"3785_CR41","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s12602-020-09711-1","volume":"13","author":"F Molham","year":"2021","unstructured":"Molham F, Khairalla AS, Azmy AF, El-Gebaly E, El-Gendy AO, AbdelGhani S. Anti-proliferative and anti-biofilm potentials of bacteriocins produced by non-pathogenic Enterococcus sp. Probiotics Antimicrob Proteins. 2021;13:571\u201385.","journal-title":"Probiotics Antimicrob Proteins"},{"key":"3785_CR42","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3389\/fmicb.2015.01271","volume":"6","author":"S Mattila","year":"2015","unstructured":"Mattila S, Ruotsalainen P, Jalasvuori M. On-Demand isolation of bacteriophages against drug-resistant bacteria for personalized phage therapy. Front Microbiol. 2015;6:1271.","journal-title":"Front Microbiol"},{"key":"3785_CR43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-1-60327-164-6_7","volume":"501","author":"AM Kropinski","year":"2009","unstructured":"Kropinski AM, Mazzocco A, Waddell TE, Lingohr E, Johnson RP. Enumeration of bacteriophages by double agar overlay plaque assay BT - bacteriophages: methods and protocols, 1: isolation, characterization, and interactions. Methods Mol Biol Humana Press. 2009;501:69\u201376.","journal-title":"Methods Mol Biol Humana Press"},{"key":"3785_CR44","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/v15030628","volume":"15","author":"M Obradovi\u0107","year":"2023","unstructured":"Obradovi\u0107 M, Male\u0161evi\u0107 M, Di Luca M, Keki\u0107 D, Gaji\u0107 I, et al. Isolation, characterization, genome analysis and host resistance development of two novel Lastavirus phages active against pandrug-resistant Klebsiella pneumoniae. Viruses. 2023;15:628.","journal-title":"Viruses"},{"key":"3785_CR45","doi-asserted-by":"publisher","first-page":"e01311","DOI":"10.1128\/AEM.01311-20","volume":"86","author":"K Abdelkader","year":"2020","unstructured":"Abdelkader K, Guti\u00e9rrez D, Grimon D, Ruas-Madiedo P, Lood C, Lavigne R, et al. Lysin LysMK34 of Acinetobacter baumannii bacteriophage PMK34 has a turgor pressure-dependent intrinsic antibacterial activity and reverts colistin resistance. Appl Environ Microbiol. 2020;86:e01311\u201320.","journal-title":"Appl Environ Microbiol"},{"key":"3785_CR46","doi-asserted-by":"publisher","first-page":"20338","DOI":"10.1038\/s41598-020-77198-5","volume":"10","author":"A Latka","year":"2020","unstructured":"Latka A, Drulis-Kawa Z. Advantages and limitations of microtiter biofilm assays in the model of antibiofilm activity of Klebsiella phage KP34 and its depolymerase. Sci Rep. 2020;10:20338.","journal-title":"Sci Rep"},{"key":"3785_CR47","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/1471-2180-14-181","volume":"14","author":"F Peng","year":"2014","unstructured":"Peng F, Mi Z, Huang Y, Yuan X, Niu W, et al. Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates. BMC Microbiol. 2014;14:181.","journal-title":"BMC Microbiol"},{"key":"3785_CR48","doi-asserted-by":"publisher","first-page":"e01092","DOI":"10.1128\/genomeA.01092-14","volume":"2","author":"S-K Choi","year":"2014","unstructured":"Choi S-K, Jeong H, Kloepper JW, Ryu C-M. Genome sequence of Bacillus amyloliquefaciens GB03, an active ingredient of the first commercial biological control product. Genome Announc. 2014;2:e01092\u201314.","journal-title":"Genome Announc"},{"key":"3785_CR49","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1093\/bioinformatics\/btu153","volume":"30","author":"T Seemann","year":"2014","unstructured":"Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30:2068\u20139.","journal-title":"Bioinformatics"},{"key":"3785_CR50","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/bioinformatics\/btm009","volume":"23","author":"AL Delcher","year":"2007","unstructured":"Delcher AL, Bratke KA, Powers EC, Salzberg SL. Identifying bacterial genes and endosymbiont DNA with glimmer. Bioinformatics. 2007;23:673\u20139.","journal-title":"Bioinformatics"},{"key":"3785_CR51","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00792-019-01147-y","volume":"24","author":"\u0160 Jane\u010dek","year":"2020","unstructured":"Jane\u010dek \u0160, Z\u00e1mock\u00e1 B. A new GH13 subfamily represented by the \u03b1-amylase from the halophilic archaeon Haloarcula hispanica. Extremophiles. 2020;24:207\u201317.","journal-title":"Extremophiles"},{"key":"3785_CR52","doi-asserted-by":"publisher","first-page":"D205","DOI":"10.1093\/nar\/gkn845","volume":"37","author":"A Marchler-Bauer","year":"2009","unstructured":"Marchler-Bauer A, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott C, Fong JH, et al. CDD: specific functional annotation with the conserved domain database. Nucleic Acids Res. 2009;37:D205\u201310.","journal-title":"Nucleic Acids Res"},{"key":"3785_CR53","doi-asserted-by":"publisher","first-page":"D351","DOI":"10.1093\/nar\/gky1100","volume":"47","author":"AL Mitchell","year":"2019","unstructured":"Mitchell AL, Attwood TK, Babbitt PC, Blum M, Bork P, Bridge A, et al. InterPro in 2019: improving coverage, classification and access to protein sequence annotations. Nucleic Acids Res. 2019;47:D351\u201360.","journal-title":"Nucleic Acids Res"},{"key":"3785_CR54","doi-asserted-by":"publisher","first-page":"e00627","DOI":"10.1128\/mBio.00627-15","volume":"6","author":"D Tan","year":"2015","unstructured":"Tan D, Svenningsen S, Lo, Middelboe M. Quorum sensing determines the choice of antiphage defense strategy in Vibrio anguillarum. MBio. 2015;6:e00627\u201315.","journal-title":"MBio"},{"issue":"04","key":"3785_CR55","first-page":"08","volume":"2022","author":"J Hallgren","year":"2022","unstructured":"Hallgren J, Tsirigos KD, Pedersen MD, Almagro Armenteros JJ, Marcatili P, Nielsen H, et al. DeepTMHMM predicts alpha and beta transmembrane proteins using deep neural networks. BioRxiv. 2022;2022(04):08\u2013487609.","journal-title":"BioRxiv"},{"key":"3785_CR56","doi-asserted-by":"publisher","first-page":"W54","DOI":"10.1093\/nar\/gkw413","volume":"44","author":"TM Lowe","year":"2016","unstructured":"Lowe TM, Chan PP. tRNAscan-SE On-line: integrating search and context for analysis of transfer RNA genes. Nucleic Acids Res. 2016;44:W54\u20137.","journal-title":"Nucleic Acids Res"},{"key":"3785_CR57","doi-asserted-by":"publisher","first-page":"W181","DOI":"10.1093\/nar\/gkn179","volume":"36","author":"JR Grant","year":"2008","unstructured":"Grant JR, Stothard P. The CGView server: a comparative genomics tool for circular genomes. Nucleic Acids Res. 2008;36:W181\u20134.","journal-title":"Nucleic Acids Res"},{"key":"3785_CR58","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/v14020342","volume":"14","author":"K Yukgehnaish","year":"2022","unstructured":"Yukgehnaish K, Rajandas H, Parimannan S, Manickam R, Marimuthu K, Petersen B, et al. PhageLeads: rapid assessment of phage therapeutic suitability using an ensemble machine learning approach. Viruses. 2022;14:342.","journal-title":"Viruses"},{"key":"3785_CR59","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/bioinformatics\/btv681","volume":"32","author":"M Richter","year":"2016","unstructured":"Richter M, Rossell\u00f3-M\u00f3ra R, Oliver Gl\u00f6ckner F, Peplies J. JSpeciesWS: a web server for prokaryotic species circumscription based on pairwise genome comparison. Bioinformatics. 2016;32:929\u201331.","journal-title":"Bioinformatics"},{"key":"3785_CR60","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.3390\/v12111268","volume":"12","author":"C Moraru","year":"2020","unstructured":"Moraru C, Varsani A, Kropinski AM. VIRIDIC - A novel tool to calculate the intergenomic similarities of prokaryote-infecting viruses. Viruses. 2020;12:1268.","journal-title":"Viruses"},{"key":"3785_CR61","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1093\/bioinformatics\/btx157","volume":"33","author":"Y Nishimura","year":"2017","unstructured":"Nishimura Y, Yoshida T, Kuronishi M, Uehara H, Ogata H, Goto S. ViPTree: the viral proteomic tree server. Bioinformatics. 2017;33:2379\u201380.","journal-title":"Bioinformatics"},{"key":"3785_CR62","doi-asserted-by":"crossref","unstructured":"Chhibber S, Kumari S. Application of therapeutic phages in medicine. In Bacteriophages. InTech; Ipek Kurtboke Ed., 2012.","DOI":"10.5772\/34296"},{"key":"3785_CR63","doi-asserted-by":"publisher","first-page":"e00034","DOI":"10.1128\/mBio.00034-21","volume":"12","author":"S Hesse","year":"2021","unstructured":"Hesse S, Malachowa N, Porter AR, Freedman B, Kobayashi SD, Gardner DJ, et al. Bacteriophage treatment rescues mice infected with multidrug-resistant Klebsiella pneumoniae ST258. MBio. 2021;12:e00034\u201321.","journal-title":"MBio"},{"key":"3785_CR64","first-page":"622","volume":"19","author":"S Kumari","year":"2009","unstructured":"Kumari S, Harjai K, Chhibber S. Efficacy of bacteriophage treatment in murine burn wound infection induced by Klebsiella pneumoniae. J Microbiol Biotechnol. 2009;19:622\u20138.","journal-title":"J Microbiol Biotechnol"},{"key":"3785_CR65","unstructured":"Laboratory of Chemical Life Science, Center B. Institute for Chemical Research, Kyoto University J. DigAlign: the Dynamic Genomic Alignment Server, version 2.0. Available from: https:\/\/www.genome.jp\/digalign\/"},{"key":"3785_CR66","doi-asserted-by":"publisher","first-page":"030006052211120","DOI":"10.1177\/03000605221112019","volume":"50","author":"R Seby","year":"2022","unstructured":"Seby R, Kim C, Khreis M, Khreis K. Enterococcus faecalis-induced infective endocarditis: an unusual source of infection and a rare clinical presentation. J Int Med Res. 2022;50:03000605221112019.","journal-title":"J Int Med Res"},{"key":"3785_CR67","doi-asserted-by":"crossref","unstructured":"Church NA, McKillip JL. Antibiotic resistance crisis: challenges and imperatives. Biol (Bratisl). 2021;76:1535\u201350.","DOI":"10.1007\/s11756-021-00697-x"},{"key":"3785_CR68","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1086\/647870","volume":"19","author":"WJ Martone","year":"1998","unstructured":"Martone WJ. Spread of Vancomycin-resistant enterococci: why did it happen in the United States? Infect Control Hosp Epidemiol. 1998;19:539\u201345.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"3785_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-9-9","volume":"9","author":"IU Haq","year":"2012","unstructured":"Haq IU, Chaudhry WN, Akhtar MN, Andleeb S, Qadri I. Bacteriophages and their implications on future biotechnology: a review. Virol J. 2012;9:1\u20138.","journal-title":"Virol J"},{"key":"3785_CR70","doi-asserted-by":"crossref","unstructured":"Moore SA, Moore AY. Phage therapy. Overcoming Antimicrob Resist Ski. 2021;195.","DOI":"10.1007\/978-3-030-68321-4_12"},{"key":"3785_CR71","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.jiph.2022.10.022","volume":"15","author":"A Alsaadi","year":"2022","unstructured":"Alsaadi A, Imam M, Alghamdi AA, Alghoribi MF. Towards promising antimicrobial alternatives: the future of bacteriophage research and development in Saudi Arabia. J Infect Public Health. 2022;15:1355\u201362.","journal-title":"J Infect Public Health"},{"key":"3785_CR72","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3390\/v11040343","volume":"11","author":"S McCallin","year":"2019","unstructured":"McCallin S, Sacher JC, Zheng J, Chan BK. Current state of compassionate phage therapy. Viruses. 2019;11:343.","journal-title":"Viruses"},{"key":"3785_CR73","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","volume":"25","author":"RM Dedrick","year":"2019","unstructured":"Dedrick RM, Guerrero-Bustamante CA, Garlena RA, Russel DA, Ford K, et al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat Med. 2019;25:730\u20133.","journal-title":"Nat Med"},{"key":"3785_CR74","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/cid\/ciac453","volume":"76","author":"RM Dedrick","year":"2023","unstructured":"Dedrick RM, Smith BE, Cristinziano M, Freeman KG, Jacobs-Sera D, Belessis Y, et al. Phage therapy of Mycobacterium infections: compassionate use of phages in 20 patients with drug-resistant mycobacterial disease. Clin Infect Dis. 2023;76:103\u201312.","journal-title":"Clin Infect Dis"},{"key":"3785_CR75","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1111\/ajt.15503","volume":"19","author":"S Aslam","year":"2019","unstructured":"Aslam S, Courtwright AM, Koval C, Lehman SM, Morales S, Furr CLL, et al. Early clinical experience of bacteriophage therapy in 3 lung transplant recipients. Am J Transpl. 2019;19:2631\u20139.","journal-title":"Am J Transpl"},{"key":"3785_CR76","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/antibiotics13090870","volume":"13","author":"L Cui","year":"2024","unstructured":"Cui L, Watanabe S, Miyanaga K, Kiga K, Sasahara T, Aiba Y, et al. A comprehensive review on phage therapy and phage-based drug development. Antibiot. 2024;13:870.","journal-title":"Antibiot"},{"key":"3785_CR77","doi-asserted-by":"publisher","first-page":"1290296","DOI":"10.3389\/fonc.2023.1290296","volume":"13","author":"MS Islam","year":"2023","unstructured":"Islam MS, Fan J, Pan F. The power of phages: revolutionizing cancer treatment. Front Oncol. 2023;13:1290296.","journal-title":"Front Oncol"},{"key":"3785_CR78","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1128\/AEM.02371-07","volume":"74","author":"J Uchiyama","year":"2008","unstructured":"Uchiyama J, Rashel M, Takemura I, Wakiguchi H, Matsuzaki S. In silico and in vivo evaluation of bacteriophage \u03c6EF24C, a candidate for treatment of Enterococcus faecalis infections. Appl Environ Microbiol. 2008;74:4149\u201363.","journal-title":"Appl Environ Microbiol"},{"key":"3785_CR79","doi-asserted-by":"crossref","unstructured":"Rahmat Ullah S, Andleeb S, Raza T, Jamal M, Mehmood K. Effectiveness of a lytic phage SRG1 against vancomycin-resistant Enterococcus faecalis in compost and soil. BioMed Res Int. 2017; 2017:9351017.","DOI":"10.1155\/2017\/9351017"},{"key":"3785_CR80","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1365-2672.2012.05361.x","volume":"113","author":"K Otawa","year":"2012","unstructured":"Otawa K, Hirakata Y, Kaku M, Nakai Y. Bacteriophage control of Vancomycin-resistant Enterococci in cattle compost. J Appl Microbiol. 2012;113:449\u2013507.","journal-title":"J Appl Microbiol"},{"key":"3785_CR81","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.copbio.2021.02.002","volume":"68","author":"J Azeredo","year":"2021","unstructured":"Azeredo J, Garc\u00eda P, Drulis-Kawa Z. Targeting biofilms using phages and their enzymes. Curr Opin Biotechnol. 2021;68:251\u201361.","journal-title":"Curr Opin Biotechnol"},{"key":"3785_CR82","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1515\/biol-2018-0066","volume":"13","author":"T Raza","year":"2018","unstructured":"Raza T, Andleeb S, Ullah SR, Jamal M, Mehmood K, Ali M. Isolation and characterization of a phage to control Vancomycin resistant Enterococcus faecium. Open Life Sci. 2018;13:553\u201360.","journal-title":"Open Life Sci"},{"key":"3785_CR83","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.3390\/v13091785","volume":"13","author":"K Paul","year":"2021","unstructured":"Paul K, Merabishvili M, Hazan R, Christner M, Herden U, Gelman D, et al. Bacteriophage rescue therapy of a Vancomycin-resistant Enterococcus faecium infection in a one-year-old child following a third liver transplantation. Viruses. 2021;13:1785.","journal-title":"Viruses"},{"key":"3785_CR84","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1534\/genetics.105.045922","volume":"172","author":"I-N Wang","year":"2006","unstructured":"Wang I-N. Lysis timing and bacteriophage fitness. Genetics. 2006;172:17\u201326.","journal-title":"Genetics"},{"key":"3785_CR85","doi-asserted-by":"publisher","first-page":"496990","DOI":"10.3389\/fmicb.2019.02877","volume":"10","author":"D Lee","year":"2019","unstructured":"Lee D, Im J, Na H, Ryu S, Yun CH, Han SH. The novel Enterococcus phage vB_EfaS_HEf13 has broad lytic activity against clinical isolates of Enterococcus faecalis. Front Microbiol. 2019;10:496990.","journal-title":"Front Microbiol"},{"key":"3785_CR86","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jbiotec.2004.08.003","volume":"115","author":"M Yoichi","year":"2005","unstructured":"Yoichi M, Abe M, Miyanaga K, Unno H, Tanji Y. Alteration of tail fiber protein gp38 enables T2 phage to infect Escherichia coli O157:H7. J Biotechnol. 2005;115:101\u20137.","journal-title":"J Biotechnol"},{"key":"3785_CR87","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1574-6968.2009.01588.x","volume":"295","author":"F Mahichi","year":"2009","unstructured":"Mahichi F, Synnott AJ, Yamamichi K, Osada T, Tanji Y. Site-specific recombination of T2 phage using IP008 long tail fiber genes provides a targeted method for expanding host range while retaining lytic activity. FEMS Microbiol Lett. 2009;295:211\u20137.","journal-title":"FEMS Microbiol Lett"},{"key":"3785_CR88","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/jobm.201200710","volume":"54","author":"WN Chaudhry","year":"2014","unstructured":"Chaudhry WN, Haq IU, Andleeb S, Qadri I. Characterization of a virulent bacteriophage LK1 specific for Citrobacter freundii isolated from sewage water. J Basic Microbiol. 2014;54:531\u201341.","journal-title":"J Basic Microbiol"},{"key":"3785_CR89","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3390\/v13061175","volume":"13","author":"ST Abedon","year":"2021","unstructured":"Abedon ST, Danis-Wlodarczyk KM, Wozniak DJ, Sullivan MB. Improving phage-biofilm in vitro experimentation. Viruses. 2021;13:1175.","journal-title":"Viruses"},{"key":"3785_CR90","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1128\/IAI.70.1.204-210.2002","volume":"70","author":"B Biswas","year":"2002","unstructured":"Biswas B, Adhya S, Washart P, Paul B, Trostel AN, Powell B, et al. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of Vancomycin-resistant Enterococcus faecium. Infect Immun. 2002;70:204\u201310.","journal-title":"Infect Immun"},{"key":"3785_CR91","doi-asserted-by":"publisher","first-page":"e80435","DOI":"10.1371\/journal.pone.0080435","volume":"8","author":"W Zhang","year":"2013","unstructured":"Zhang W, Mi Z, Yin X, Fan H, An X, Zhang Z, et al. Characterization of Enterococcus faecalis phage IME-EF1 and its endolysin. PLoS ONE. 2013;8:e80435.","journal-title":"PLoS ONE"},{"key":"3785_CR92","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1574-6968.2007.00996.x","volume":"278","author":"J Uchiyama","year":"2008","unstructured":"Uchiyama J, Rashel M, Maeda Y, Takemura I, Sugihara S, Akechi K, et al. Isolation and characterization of a novel Enterococcus faecalis bacteriophage \u03c6EF24C as a therapeutic candidate. FEMS Microbiol Lett. 2008;278:200\u20136.","journal-title":"FEMS Microbiol Lett"},{"key":"3785_CR93","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/v11030265","volume":"11","author":"S Djebara","year":"2019","unstructured":"Djebara S, Maussen C, De Vos D, Merabishvili M, Damanet B, Pang KW, et al. Processing phage therapy requests in a Brussels Military Hospital: lessons identified. Viruses. 2019;11:265.","journal-title":"Viruses"},{"key":"3785_CR94","unstructured":"Scottish Health Technologies Group\u2013 Health Improvement Scotland. SHTG recommendations, in response to enquiries from a clinical bacteriophage specialist. February 2023, Available at: https:\/\/shtg.scot\/media\/2325\/20230113-shtg-recommendation-for-bacteriophage-therapy-v10.pdf"},{"key":"3785_CR95","doi-asserted-by":"publisher","first-page":"1210319","DOI":"10.3389\/fmicb.2023.1210319","volume":"14","author":"F Song","year":"2023","unstructured":"Song F, Sheng J, Tan J, Xie H, Wang X, Guo W. Characterization of an Enterococcus faecalis bacteriophage SFQ1 as a potential therapeutic agent. Front Microbiol. 2023;14:1210319.","journal-title":"Front Microbiol"},{"key":"3785_CR96","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/v16081275","volume":"16","author":"O Soro","year":"2024","unstructured":"Soro O, Kigen C, Nyerere A, Gachoya M, Georges M, Odoyo E, et al. Characterization and anti-biofilm activity of lytic Enterococcus phage vB_Efs8_KEN04 against clinical isolates of multidrug-resistant Enterococcus faecalis in Kenya. Viruses. 2024;16:1275.","journal-title":"Viruses"},{"key":"3785_CR97","first-page":"1","volume":"4","author":"AJ Curtright","year":"2011","unstructured":"Curtright AJ, Abedon ST. Phage therapy: emergent property pharmacology. J Bioanal Biomed. 2011;4:1\u201314.","journal-title":"J Bioanal Biomed"},{"key":"3785_CR98","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3109\/07853890108995959","volume":"33","author":"A Sulakvelidze","year":"2001","unstructured":"Sulakvelidze A, Morris JG. Bacteriophages as therapeutic agents. Ann Med. 2001;33:507\u20139.","journal-title":"Ann Med"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03785-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-03785-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03785-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:02:11Z","timestamp":1740027731000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-03785-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3785"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-03785-z","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"27 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Beni-Suef University\u2019s Institutional Animal Care and Use Committee (BSU-IACUC) has approved the protocol for the animal study (Approval number: 022\u2013243).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}